A MYRISTOYL GROUP (DERIVED FROM MYRISTIC ACID) IS COVALENTLY ATTACHED TO THE N-TERMINUS VIA AN AMIDE BOND.
-
実験情報
-
実験
実験
手法: 溶液NMR
NMR実験
Conditions-ID
Experiment-ID
Solution-ID
タイプ
1
1
1
2D 1H-15N HSQC
1
2
3
3D HNCO
1
3
2
3D HNCA
1
4
2
3D HN(CA)CB
1
5
2
3DCBCA(CO)NH
1
6
2
3DHBHA(CO)NH
1
7
1
3D 1H-15N TOCSY
1
8
1
3D 1H-15N NOESY
1
9
3
3D HN(CA)CB
-
試料調製
詳細
Solution-ID
内容
溶媒系
1
5 mM [U-100% 2H] TRIS, 5 mM [U-100% 2H] DTT, 0.5 mM [U-100% 15N] GCAP1 (V77E) mutant, 5 mM MgCl2, 93 % H2O, 7 % [U-100% 2H] D2O, 93% H2O/7% D2O
93% H2O/7% D2O
2
5 mM [U-100% 2H] TRIS, 5 mM [U-100% 2H] DTT, 0.5 mM [U-100% 13C; U-100% 15N] GCAP1 (V77E) mutant, 5 mM MgCl2, 93 % H2O, 7 % [U-100% 2H] D2O, 93% H2O/7% D2O
93% H2O/7% D2O
3
5 mM [U-100% 2H] TRIS, 5 mM [U-100% 2H] DTT, 0.5 mM [U-13C; U-15N; U-2H] GCAP1 (V77E) mutant, 5 mM MgCl2, 93 % H2O, 7 % [U-100% 2H] D2O, 93% H2O/7% D2O
93% H2O/7% D2O
試料
濃度 (mg/ml)
構成要素
Isotopic labeling
Solution-ID
5mM
TRIS-1
[U-100% 2H]
1
5mM
DTT-2
[U-100% 2H]
1
0.5mM
GCAP1 (V77E) mutant-3
[U-100% 15N]
1
5mM
MgCl2-4
1
93 %
H2O-5
1
7 %
D2O-6
[U-100% 2H]
1
5mM
TRIS-7
[U-100% 2H]
2
5mM
DTT-8
[U-100% 2H]
2
0.5mM
GCAP1 (V77E) mutant-9
[U-100% 13C; U-100% 15N]
2
5mM
MgCl2-10
2
93 %
H2O-11
2
7 %
D2O-12
[U-100% 2H]
2
5mM
TRIS-13
[U-100% 2H]
3
5mM
DTT-14
[U-100% 2H]
3
0.5mM
GCAP1 (V77E) mutant-15
[U-13C; U-15N; U-2H]
3
5mM
MgCl2-16
3
93 %
H2O-17
3
7 %
D2O-18
[U-100% 2H]
3
試料状態
イオン強度: 20 / pH: 7.4 / 圧: 1 atm / 温度: 320 K
-
NMR測定
NMRスペクトロメーター
タイプ: Bruker Avance / 製造業者: Bruker / モデル: AVANCE / 磁場強度: 800 MHz
-
解析
NMR software
名称
開発者
分類
NMRPipe
Delaglio, Grzesiek, Vuister, Zhu, PfeiferandBax
解析
Sparky
Goddard
chemicalshiftassignment
XPLOR-NIH
精密化
精密化
手法: simulated annealing / ソフトェア番号: 1 詳細: A template homology model structure was refined using a refinement protocol of XPLOR-NIH with restraints from experimental data and, primary and secondary sequential analysis.
代表構造
選択基準: lowest energy
NMRアンサンブル
コンフォーマー選択の基準: structures with the lowest energy 計算したコンフォーマーの数: 500 / 登録したコンフォーマーの数: 15